Skip to main content
. 2022 Feb 3;13:671. doi: 10.1038/s41467-022-28291-y

Table 1.

Summary of study cohort.

Wave 1 Wave 2
Dates 1st March 2020 to 25th July 2020 30th November 2020 to 24th January 2021
Total Cases 1302 879
   Patients 780 (59.9%) 580 (66.0%)
   Staff 522 (40.1%) 299 (34.0%)
Number of hospital locations 120 93
Global PANGO lineages 64 24
Fraction of patients with inferred symptom onset date 30.1% 22.0%
Median ward movements per patient (min-max) 2 (1–9) 2 (1–9)
Patient classification
   Community onset—community associated 486 (62.3%*) 236 (40.7%*)
   Community onset—suspected healthcare associated 79 (10.1%*) 67 (11.6%*)
   Hospital onset—healthcare associated 80 (10.3%*) 100 (17.2%*)
   Hospital onset—probable healthcare associated 74 (9.5%*) 88 (15.2%*)
   Hospital onset—intermediate healthcare associated 61 (7.8%*) 89 (15.3%*)

Number of hospital locations includes wards and non-clinical areas. Ward movements refer to between ward movements and do not include bed movements within the same ward. Classification of patient cases according to likely source of infection (community or hospital-acquired) is based on SAGE criteria15. Community onset-community associated = positive test up to 14 days before or within 2 days after hospital admission; Community onset-suspected healthcare associated = positive test up to 14 days before or within 2 days after admission, with discharge from hospital within 14 days before test; Hospital onset-intermediate healthcare associated = positive test 3–7 days after hospital admission with no discharge from hospital in 14 days before the specimen date; Hospital onset-suspected healthcare associated = positive test 8–14 days after admission or 3–14 days after admission with discharge from hospital in 14 days before test; Hospital onset-healthcare associated =  positive test 15 or more days after hospital admission. Asterix represents percentage of patient cases.